The functional genomic studies of resveratrol in respect to its anti-cancer effects

Biotechnol Adv. 2018 Nov 1;36(6):1699-1708. doi: 10.1016/j.biotechadv.2018.02.011. Epub 2018 Feb 22.

Abstract

Resveratrol has anti-cancer effects in vitro, and hypothetical chemopreventive effects in vivo. Effects are pleiotropic, mediated by changes in expression of many genes and epigenetic reprogramming. Thus, they are well suited for functional genomic studies. We carried out systematic review of such studies (reflecting also on technological progress). Differentially expressed genes commonly linked to resveratrol treatment were linked to cell cycle, proliferation, and apoptosis. However, it is unclear if these are primary and specific targets of resveratrol. We conclude by discussing areas where additional functional genomic studies are desirable, including experiments that better model in vivo effects of dietary intake.

Keywords: Apoptosis; Cancer; Functional genomics; Microarrays; Proliferation; Resveratrol.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Gene Expression Profiling
  • Genomics / methods*
  • Humans
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • Resveratrol / pharmacology*
  • Transcriptome / drug effects

Substances

  • Antineoplastic Agents
  • Resveratrol